Yigal Nochomovitz
Stock Analyst at Citigroup
(2.27)
# 2,442
Out of 4,831 analysts
296
Total ratings
36.75%
Success rate
-1.93%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARVN Arvinas | Maintains: Neutral | $10 → $9.5 | $6.11 | +55.48% | 10 | May 5, 2025 | |
| ARDX Ardelyx | Maintains: Buy | $11 → $10 | $3.34 | +199.40% | 15 | May 2, 2025 | |
| SMMT Summit Therapeutics | Upgrades: Buy | $23 → $35 | $23.72 | +47.55% | 5 | Mar 26, 2025 | |
| LENZ LENZ Therapeutics | Maintains: Buy | $44 → $47 | $27.51 | +70.85% | 2 | Mar 20, 2025 | |
| ZYME Zymeworks | Maintains: Buy | $18 → $19 | $11.27 | +68.66% | 16 | Mar 7, 2025 | |
| RIGL Rigel Pharmaceuticals | Maintains: Buy | $49 → $55 | $18.11 | +203.70% | 11 | Mar 6, 2025 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $45 → $42 | $9.76 | +330.33% | 8 | Mar 4, 2025 | |
| KRYS Krystal Biotech | Maintains: Neutral | $206 → $215 | $129.37 | +66.20% | 4 | Feb 20, 2025 | |
| CADL Candel Therapeutics | Initiates: Buy | $25 | $5.51 | +353.72% | 1 | Feb 20, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $89 → $82 | $36.16 | +126.77% | 21 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $5.50 | +500.00% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $97 | $40.62 | +138.80% | 16 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $8 | $0.47 | +1,602.13% | 10 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $6 | $0.78 | +667.07% | 5 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $63 → $51 | $16.82 | +203.21% | 14 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $8.73 | +209.28% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 → $2 | $0.98 | +104.77% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $19.00 | +89.47% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $17.01 | +240.98% | 3 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $22 | $1.52 | +1,352.15% | 8 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $1.54 | +812.05% | 14 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $1.2 | $0.29 | +308.58% | 9 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $38 | $8.52 | +346.01% | 7 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $5.01 | +179.44% | 6 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.8 → $2 | $1.53 | +31.15% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $123 → $66 | $27.92 | +136.43% | 8 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $11.15 | +330.49% | 5 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.14 | +383.09% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $8 | $2.05 | +290.24% | 10 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1 | $6.29 | -84.10% | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $50 → $35 | $6.60 | +430.30% | 12 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $133 | $34.80 | +282.18% | 15 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $8 | $0.56 | +1,328.38% | 11 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $6 | $0.82 | +628.60% | 7 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $16 | $1.40 | +1,042.86% | 3 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $0.98 | +919.89% | 6 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $0.79 | +1,924.04% | 1 | Oct 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $44 | $3.41 | +1,190.32% | 2 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $2.13 | +463.38% | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $2.91 | - | 14 | Sep 28, 2021 |
Arvinas
May 5, 2025
Maintains: Neutral
Price Target: $10 → $9.5
Current: $6.11
Upside: +55.48%
Ardelyx
May 2, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $3.34
Upside: +199.40%
Summit Therapeutics
Mar 26, 2025
Upgrades: Buy
Price Target: $23 → $35
Current: $23.72
Upside: +47.55%
LENZ Therapeutics
Mar 20, 2025
Maintains: Buy
Price Target: $44 → $47
Current: $27.51
Upside: +70.85%
Zymeworks
Mar 7, 2025
Maintains: Buy
Price Target: $18 → $19
Current: $11.27
Upside: +68.66%
Rigel Pharmaceuticals
Mar 6, 2025
Maintains: Buy
Price Target: $49 → $55
Current: $18.11
Upside: +203.70%
Syndax Pharmaceuticals
Mar 4, 2025
Maintains: Buy
Price Target: $45 → $42
Current: $9.76
Upside: +330.33%
Krystal Biotech
Feb 20, 2025
Maintains: Neutral
Price Target: $206 → $215
Current: $129.37
Upside: +66.20%
Candel Therapeutics
Feb 20, 2025
Initiates: Buy
Price Target: $25
Current: $5.51
Upside: +353.72%
CRISPR Therapeutics AG
Feb 18, 2025
Maintains: Buy
Price Target: $89 → $82
Current: $36.16
Upside: +126.77%
Jan 7, 2025
Initiates: Buy
Price Target: $33
Current: $5.50
Upside: +500.00%
Dec 9, 2024
Maintains: Buy
Price Target: $89 → $97
Current: $40.62
Upside: +138.80%
Nov 29, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $0.47
Upside: +1,602.13%
Nov 26, 2024
Maintains: Buy
Price Target: $30 → $6
Current: $0.78
Upside: +667.07%
Nov 6, 2024
Maintains: Buy
Price Target: $63 → $51
Current: $16.82
Upside: +203.21%
Oct 8, 2024
Initiates: Buy
Price Target: $27
Current: $8.73
Upside: +209.28%
Oct 2, 2024
Downgrades: Neutral
Price Target: $8 → $2
Current: $0.98
Upside: +104.77%
Sep 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $19.00
Upside: +89.47%
Aug 27, 2024
Maintains: Buy
Price Target: $60 → $58
Current: $17.01
Upside: +240.98%
Aug 27, 2024
Maintains: Buy
Price Target: $45 → $22
Current: $1.52
Upside: +1,352.15%
Aug 15, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $1.54
Upside: +812.05%
Jun 18, 2024
Maintains: Neutral
Price Target: $3.5 → $1.2
Current: $0.29
Upside: +308.58%
Jun 3, 2024
Maintains: Buy
Price Target: $36 → $38
Current: $8.52
Upside: +346.01%
May 7, 2024
Maintains: Buy
Price Target: $15 → $14
Current: $5.01
Upside: +179.44%
Apr 18, 2024
Maintains: Neutral
Price Target: $1.8 → $2
Current: $1.53
Upside: +31.15%
Feb 29, 2024
Maintains: Buy
Price Target: $123 → $66
Current: $27.92
Upside: +136.43%
Feb 8, 2024
Maintains: Buy
Price Target: $40 → $48
Current: $11.15
Upside: +330.49%
Jan 30, 2024
Initiates: Buy
Price Target: $20
Current: $4.14
Upside: +383.09%
Oct 17, 2023
Maintains: Buy
Price Target: $25 → $8
Current: $2.05
Upside: +290.24%
Sep 18, 2023
Maintains: Neutral
Price Target: $1.5 → $1
Current: $6.29
Upside: -84.10%
Aug 21, 2023
Maintains: Sell
Price Target: $50 → $35
Current: $6.60
Upside: +430.30%
Jun 7, 2023
Maintains: Buy
Price Target: $130 → $133
Current: $34.80
Upside: +282.18%
May 31, 2023
Maintains: Buy
Price Target: $6 → $8
Current: $0.56
Upside: +1,328.38%
May 26, 2023
Maintains: Buy
Price Target: $5 → $6
Current: $0.82
Upside: +628.60%
Apr 5, 2023
Maintains: Buy
Price Target: $24 → $16
Current: $1.40
Upside: +1,042.86%
Mar 2, 2023
Maintains: Buy
Price Target: $9 → $10
Current: $0.98
Upside: +919.89%
Oct 14, 2022
Initiates: Buy
Price Target: $16
Current: $0.79
Upside: +1,924.04%
Sep 16, 2022
Maintains: Buy
Price Target: $45 → $44
Current: $3.41
Upside: +1,190.32%
Sep 16, 2022
Maintains: Buy
Price Target: $16 → $12
Current: $2.13
Upside: +463.38%
Sep 28, 2021
Upgrades: Buy
Price Target: n/a
Current: $2.91
Upside: -